Pregabalin and gabapentin for post-photorefractive keratectomy pain: A randomized controlled trial

European Journal of Ophthalmology

Volumn 22, Issue SUPPLEMENT N. 7, 2012, Pages

  Pakravan, Mohammad ^a   Roshani, Maryam ^a   Yazdani, Shahin ^a   Faramaz, Amir ^a   Yaseri, Mehdi ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gabapentin; Photorefractive keratectomy; Postoperative pain; Pregabalin

Indexed keywords

COCODAMOL; GABAPENTIN; MITOMYCIN C; PLACEBO; PREGABALIN; 4 AMINOBUTYRIC ACID; ACETAMINOPHEN, CODEINE DRUG COMBINATION; AMINE; ANALGESIC AGENT; CODEINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; DRUG DERIVATIVE; PARACETAMOL;

ADJUVANT THERAPY; ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN ASSESSMENT; PHOTOREFRACTIVE KERATECTOMY; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; EYE PAIN; ORAL DRUG ADMINISTRATION; PROSPECTIVE STUDY;

ACETAMINOPHEN; ADMINISTRATION, ORAL; ADULT; AMINES; ANALGESICS; CODEINE; CYCLOHEXANECARBOXYLIC ACIDS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; EYE PAIN; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PHOTOREFRACTIVE KERATECTOMY; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863746211     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/ejo.5000143     Document Type: Article

References (27)

1. Wilson SE. Clinical practice. Use of lasers for vision correction of nearsightedness and farsightedness. N Engl J Med 2004; 351: 470-5.
2. Ambrósio R Jr, Wilson S. LASIK vs LASEK vs PRK: advantages and indications. Semin Ophthalmol 2003; 18: 2-10.
3. Steinert RF, Bafna S. Surgical correction of moderate myopia: which method should you choose? II. PRK and LASIK are the treatments of choice. Surv Ophthalmol 1998; 43: 157-79.
4. Donnenfeld ED, Holland EJ, Durrie DS, Raizman MB. Doublemasked study of the effects of nepafenac 0.1% and ketorolac 0.4% on corneal epithelial wound healing and pain after photorefractive keratectomy. Adv Ther 2007; 24: 852-62.
5. Torres LF, Sancho C, Tan B, Padilla K, Schanzlin DJ, Chayet AS. Early postoperative pain following Epi-LASIK and photorefractive keratectomy: a prospective, comparative, bilateral study. J Refract Surg 2007; 23: 126-32.
6. Solomon KD, Donnenfeld ED, Raizman M, et al; Ketorolac Reformulation Study Groups 1 and 2. Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in postphotorefractive keratectomy patients. J Cataract Refract Surg 2004; 30: 1653-60.
7. Durrie DS, Kennard MG, Boghossian AJ. Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK). Adv Ther 2007; 24: 1278-85.
8. Weinstock VM, Weinstock DJ, Weinstock SJ. Diclofenac and ketorolac in the treatment of pain after photorefractive keratectomy. J Refract Surg 1996; 12: 792-4.
9. Wiffen PJ, McQuay HJ, Edwards JE, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005; 20: CD005452.
10. Hurley RW, Cohen SP, Williams KA, Rowlingson AJ, Wu CL. The analgesic effects of perioperative gabapentin on postoperative pain: a meta-analysis. Reg Anesth Pain Med 2006; 31: 237-47.
11. Mellegers MA, Furlan AD, Mailis A. Gabapentin for neuropathic pain: systematic review of controlled and uncontrolled literature. Clin J Pain 2001; 17: 284-95.
12. Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 2004; 45 (Suppl 6): 13-8.
13. Shneker BF, McAuley JW. Pregabalin: a new neuromodulator with broad therapeutic indications. Ann Pharmacother 2005; 39: 2029-37.
14. Chizh BA, Göhring M, Tröster A, Quartey GK, Schmelz M, Koppert W. Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers. Br J Anaesth 2007; 98: 246-54.
15. Guay DR. Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin? Am J Geriatr Pharmacother 2005; 3: 274-87.
16. Frampton JE, Foster RH. Pregabalin: in the treatment of postherpetic neuralgia. Drugs 2005; 65: 111-8, discussion 119-20.
17. Jones DL, Sorkin LS. Systemic gabapentin and S(+)-3-isobutyl- gamma-aminobutyric acid block secondary hyperalgesia. Brain Res 1998; 810: 93-9.
18. Nissman SA, Tractenberg RE, Babbar-Goel A, Pasternak JF. Oral gabapentin for the treatment of postoperative pain after photorefractive keratectomy. Am J Ophthalmol 2008; 145: 623-9.
19. Kuhnle MD, Ryan DS, Coe CD, et al. Oral gabapentin for photorefractive keratectomy pain. J Cataract Refract Surg 2011; 37: 364-9.
20. Baillie JK, Power I. The mechanism of action of gabapentin in neuropathic pain. Curr Opin Investig Drugs 2006; 7: 33-9.
21. Eroglu C, Allen NJ, Susman MW, et al. Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 2009; 139: 380-92.
22. Heblich F, Tran Van Minh A, Hendrich J, Watschinger K, Dolphin AC. Time course and specificity of the pharmacological disruption of the trafficking of voltage-gated calcium channels by gabapentin. Channels 2008; 2: 4-9.
23. Davies A, Hendrich J, Van Minh AT, Wratten J, Douglas L, Dolphin AC. Functional biology of the alphadelta subunits of voltage-gated calcium channels. Trends Pharmacol Sci 2007; 28: 220-8.
24. Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet 2010; 49: 661-9.
25. Gajraj NM. Pregabalin: its pharmacology and use in pain management. Anesth Analg 2007; 105: 1805-15.
26. Hill CM, Balkenohl M, Thomas DW, Walker R, Mathé H, Murray G. Pregabalin in patients with postoperative dental pain. Eur J Pain 2001; 5: 119-24.
27. Hanna M, O'Brien C, Wilson MC. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 2008; 12: 804-13.